SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
166.60    -4.20 (-2.46%)
Bid:
166.40
Ask:
167.20
Spread: 0.80 (0.481%)
Market Cap: £203.82m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

Chair tenure extension

Today 12:41

RNS Number : 3454I
SThree plc
15 June 2026
ย 

15 June 2026

ย 

SThree - Chair tenure extension

ย 

SThree plc, the global STEM workforce consultancy, announces that, after consultation with shareholders, the Board is extending James Bilefield's tenure as Chair for a seven-month period, until April 2027. This extension allows James, as Chair of the Nomination Committee, to conclude the search for a permanent Chief Financial Officer, before the Nomination Committee turns its focus to Chair succession.

ย 

James was appointed to the Board in October 2017, becoming Chair in April 2018. James' nine-year term will therefore conclude in September 2026. The Nomination Committee recommended to the Board a short, time-bound extension for James to remain as Chair until the conclusion of the Company's annual general meeting in April 2027.

ย 

Imogen Joss, Senior Independent Non-Executive Director, commented:

"I am delighted that James has agreed to this short extension of tenure. He has been a strong independent director throughout his time at SThree and a valued source of support to the Executive Team. We are very grateful for his continued contribution and believe this extension is in the best interests of the Company."

ย 

Enquiries:

ย 

SThree plc

Timo Lehne, CEO

Damian Fehrenberg, Interim CFO

Charlie Hildesley, Investor Relations Manager

ย 

ย 

ย via Alma

Alma Strategic Communications

+44 20 3405 0205

ย 

Rebecca Sanders-Hewett

Hilary Buchanan

Sam Modlin

Rose Docherty

SThree@almastrategic.com

ย 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ย 
END
ย 
ย 
MSCAKPBNDBKDFAD
Date   Source Headline
15th Jun 202612:41 pmRNSChair tenure extension
15th Jun 202612:33 pmRNSDirector/PDMR Shareholding
12th Jun 20267:00 amRNSTransaction in Own Shares
11th Jun 20269:53 amRNSHolding(s) in Company
5th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20265:25 pmRNSHolding(s) in Company
1st Jun 202612:29 pmRNSTotal Voting Rights
29th May 20267:00 amRNSTransaction in Own Shares
26th May 20264:00 pmRNSHolding(s) in Company
26th May 20269:30 amRNSHolding(s) in Company
22nd May 20263:00 pmRNSDirector/PDMR Shareholding
22nd May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
12th May 20265:16 pmRNSDirector/PDMR Shareholding
8th May 20267:00 amRNSTransaction in Own Shares
1st May 20269:51 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20263:30 pmRNSHolding(s) in Company
29th Apr 202612:20 pmRNSResult of AGM
24th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 202610:35 amRNSHolding(s) in Company
14th Apr 202610:29 amRNSHolding(s) in Company
13th Apr 20264:45 pmRNSDirector/PDMR Shareholding
13th Apr 20263:38 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20264:14 pmRNSHolding(s) in Company
7th Apr 20269:30 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202612:18 pmRNSTotal Voting Rights
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20262:37 pmRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20263:37 pmRNSPurchase of shares into the EBT
17th Mar 20269:50 amRNSHolding(s) in Company
17th Mar 20267:01 amRNSCFO departure and succession plan
17th Mar 20267:01 amRNSCFO departure and succession plan
17th Mar 20267:00 amRNSFY26 Q1 Trading Update
17th Mar 20267:00 amRNSFY26 Q1 Trading Update
13th Mar 20263:30 pmRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20264:12 pmRNSDirector/PDMR Shareholding
10th Mar 20264:12 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 202611:00 amRNSAnnual Financial Report
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.